Riskpilot← Back to searchSign inGet full accessNOVO HELSESENTER AS
ASActiveOrg 921014538Gladbakkvegen 2, 2070 RåholtGeneral medical practice activities · NACE 8621Est. 20186 employees
Revenue 2025
NOK 5,7M
+17% vs 2024
EBITDA margin
0.0%
+100% vs 2024
Equity ratio
-65.0%
Financial strength
Net profit 2025
NOK 429
+100% vs 2024
| Revenue | NOK 5,7M | +17% |
| EBITDA | NOK 461 | +100% |
| Net profit | NOK 429 | +100% |
| Total assets | NOK 495K | +39% |
| Equity | NOK -322K | +0% |
| Employees | 6 | — |
Legal name
NOVO HELSESENTER AS
Org number
921014538
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
2. juli 2018
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Å drive legevirksomhet, legesentervirksomhet, undervisning og rådgivning, konsulentvirksomhet, herunder å eie andeler og aksjer i andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Gladbakkvegen 2, 2070 Råholt
Phone
+4763961500
Email
post@novohelsesenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 300 | 3 214 | 3 401 | 4 862 | 5 669 |
| Staff expenses | −741 | −796 | −1 084 | −1 729 | −2 429 |
| EBITDA | −64 | 469 | −33 | −177 | 0 |
| Depreciation & amort. | −86 | −86 | −89 | −68 | −0 |
| EBIT | −150 | 383 | −122 | −245 | 0 |
| Net financials | −8 | −0 | −1 | 0 | −0 |
| Profit before tax | −157 | 383 | −123 | −245 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −157 | 383 | −123 | −245 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 454 | 298 | 358 | 356 | 495 |
| Equity | −337 | 46 | −77 | −322 | −322 |
| Long-term debt | 409 | 0 | 0 | 0 | 0 |
| Short-term debt | 382 | 252 | 435 | 678 | 817 |
| Total debt | 791 | 252 | 435 | 678 | 817 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
-65.0%
This company
38.2%
Market median
-270% vs market
20212025
Return on equity
42900.0%
This company
18.4%
Market median
+233052% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
11.45×
This company
1.12×
Market median
+922% vs market
20212025
Debt / equity
2.54×
This company
0.62×
Market median
-310% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PL Chief Executive Officer | Chief Executive Officer | 2024 |
AJ Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
SA Deputy Member | Deputy Member | 2018 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Chairman | 2018 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NOVO HELSESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sadia Aziz Malik | Deputy Member | 0 companies |
| Paulina Latkowska | Chief Executive Officer | 0 companies |
| Anneli Jerijærvi | Chief Executive Officer | 0 companies |
| Choudhry Nabeel Mukhtar | Board of Directors | 0 companies |
| Usman Akram Ansari | Chairman | 0 companies |
| Anders Christoffersen | Board of Directors | 0 companies |